Komminoth, P; Perren, Aurel (2015). What is new in the pathology of pancreatic neuroendocrine tumors? Pathologe, 36(3), pp. 220-228. Springer-Medizin-Verlag 10.1007/s00292-015-0023-1
|
Text
art%3A10.1007%2Fs00292-015-0023-1.pdf - Published Version Available under License Publisher holds Copyright. Download (1MB) | Preview |
The diagnostics of pancreatic neuroendocrine tumors (PanNEN) have changed in recent years especially concerning the World Health Organization (WHO) classification, TNM staging and grading. Furthermore, some new prognostic and predictive immunohistochemical markers have been introduced. Most progress, however, has been made in the molecular pathogenesis of these neoplasms. Using next generation sequencing techniques, the mammalian target of rapamycin (mTOR) pathway, hypoxia and epigenetic changes were identified as key players in tumorigenesis. In this article the most important developments of morphological as well as immunohistochemical diagnostics together with the molecular background of PanNEN are summarized.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Perren, Aurel |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
0172-8113 |
Publisher: |
Springer-Medizin-Verlag |
Language: |
German |
Submitter: |
Doris Haefelin |
Date Deposited: |
14 Jul 2015 11:12 |
Last Modified: |
05 Dec 2022 14:48 |
Publisher DOI: |
10.1007/s00292-015-0023-1 |
PubMed ID: |
25941099 |
BORIS DOI: |
10.7892/boris.70230 |
URI: |
https://boris.unibe.ch/id/eprint/70230 |
Actions (login required)
 |
Edit item |